Roche Holding AG (RHHBY)
OTCMKTS
· Delayed Price · Currency is USD
39.60
-0.36 (-0.90%)
Sep 26, 2025, 3:58 PM EDT
Roche Holding AG Employees
Roche Holding AG had 103,249 employees as of December 31, 2024. The number of employees decreased by 356 or -0.34% compared to the previous year.
Employees
103,249
Change (1Y)
-356
Growth (1Y)
-0.34%
Revenue / Employee
$773,189
Profits / Employee
$114,831
Market Cap
272.45B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 103,249 | -356 | -0.34% |
| Dec 31, 2023 | 103,605 | -8 | -0.01% |
| Dec 31, 2022 | 103,613 | 2,693 | 2.67% |
| Dec 31, 2021 | 100,920 | -545 | -0.54% |
| Dec 31, 2020 | 101,465 | 3,730 | 3.82% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tian'an Technology Group | 8 |
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
Roche Holding AG News
- 3 days ago - Roche points to U.S. plans after Trump pharma tariff announcement - Reuters
- 4 days ago - Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial - CNBC
- 5 days ago - Roche presents new data for OCREVUS and fenebrutinib across broad patient populations at ECTRIMS 2025 - GlobeNewsWire
- 5 days ago - Genentech Presents New Data for Ocrevus and Fenebrutinib Across Broad Patient Populations at ECTRIMS 2025 - Business Wire
- 5 days ago - Roche's Giredestrant: A Ray Of Hope On A Cloudy Horizon? - Seeking Alpha
- 6 days ago - Roche Holding AG - Special Call - Seeking Alpha
- 6 days ago - Roche Targets Top Spot In Weight Loss Drug Market - Benzinga
- 6 days ago - Roche Targets Top Spot In Weight Loss Drug Market - Benzinga